Abramson Cancer Center At Penn Medicine
Clinical trials sponsored by Abramson Cancer Center At Penn Medicine, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Lung cancer Treatment's hidden heart risk under the microscope Results expected Sep 2026 (estimated)
- Could a ketone drink boost CAR-T success in lymphoma? Results expected Sep 2026 (estimated)
- New drug cocktail aims to shrink lung tumors after standard treatment fails Results expected Sep 2026 (estimated)
- Can a simple screening improve breast cancer care? study investigates Results expected Sep 2026 (estimated)
- New study explores how genetic risk info shapes ovarian cancer decisions Results expected Oct 2026 (estimated)
-
PET scans may help supercharge immune cell therapy against melanoma
Disease control Not yet recruitingThis pilot study explores whether a special PET/CT scan that tracks CD8 immune cells can help select the best tumors for harvesting immune cells (TILs) to treat stage IV melanoma. Participants receive the TIL therapy lifileucel (AMTAGVI) after a chemotherapy regimen. The goal is …
Early phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New combo aims to tame HPV throat cancer with fewer side effects
Disease control Not yet recruitingThis early-phase trial tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation to the neck can safely and effectively treat early-stage HPV-positive throat cancer before surgery. About 35 participants will take the drug daily for 10 days and receive …
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a One-Time treatment give kidney cancer patients a year off drugs?
Disease control Not yet recruitingThis study tests whether giving focused radiation or surgery to all visible tumors (both the original kidney tumor and its metastases) can allow people with advanced kidney cancer to stop all cancer treatments for at least a year. Participants must have stable or partially improv…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden sarcoma tumors in Children's lungs
Disease control Not yet recruitingThis pilot study tests whether a dye called TumorGlow (indocyanine green) can help surgeons see and remove sarcoma tumors that have spread to the lungs in children aged 12 to 17. The dye is given intravenously up to five days before surgery, and during the operation, a special ca…
Early phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Cancer-Killing virus injected into tumors before surgery: a new hope?
Disease control Not yet recruitingThis study tests whether injecting a virus called RP2 directly into stomach and esophageal tumors, combined with standard FLOT chemotherapy, is safe and works better than chemotherapy alone before surgery. About 34 people with stage II or higher non-metastatic gastroesophageal ca…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
A new MRI tracer might reveal if liver cancer treatment is working
Diagnosis Not yet recruitingThis study tests whether a specialized MRI technique can predict how well liver cancer responds to treatments like embolization, ablation, or systemic therapy. Researchers will use an imaging agent called hyperpolarized pyruvate to measure tumor metabolism in adults with intermed…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
MRI scans may reveal which throat cancer patients need stronger treatment
Diagnosis Not yet recruitingThis study tests whether special MRI scans can predict how well HPV-positive throat cancer responds to standard chemotherapy and radiation. Researchers will scan 30 adults before treatment and track their outcomes. The goal is to see if MRI patterns can identify low-risk patients…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
New blood test could spot breast cancer earlier
Diagnosis Not yet recruitingThis study will check how well a new blood test, called SpotitEarly, can detect breast cancer in women. About 500 women will take part, including those at higher risk due to age, genetics, or family history. The goal is to see if the test is accurate and works well for different …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Apr 28, 2026 13:01 UTC